Assessment of Light Therapy in Insomnia Disorder (InsomLum)
Insomnia
About this trial
This is an interventional treatment trial for Insomnia
Eligibility Criteria
Inclusion Criteria: Patient aged 30 to 60 years Insomnia disorders (ICSD-3) with sleep latency >30min - 3 times a week Patient able to understand the objectives and risks associated with the research and to give informed dated and signed consent Patient affiliated to a social health insurance scheme For women of childbearing age, effective contraceptive measure for the duration of the research (hormonal contraception, IUD). Exclusion Criteria: - Shift work in the year preceding inclusion Trans meridian travel (> 2 time zones) in the month preceding inclusion Patient in exclusion period determined by a previous or ongoing study Impossibility of giving the patient informed information (emergency patient, difficulty understanding the patient) Patient under judicial protection Patient under guardianship or curatorship For a woman of childbearing age: ongoing pregnancy or breastfeeding Drug treatment which can disturb sleep or the measurement of DLMO: corticosteroids by general route, beta-blockers in the evening, exogenous melatonin. Phase delay syndrome defined according to the criteria of the international classification of ICSD-3 Restless legs syndrome with IRLS score> 20 Other psychiatric disorders or addictive disorder (screening with the MINI structured interview) Other medical conditions not stabilized (detected by clinical interview), only the diseases appearing in the following list will constitute a criterion of non-inclusion: Chronic allergies Neurological disorders cardiovascular, respiratory, gastrointestinal, hematopoietic, visual diseases diseases of the immune system kidney and urinary tract diseases endocrine and metabolic diseases infectious diseases epilepsy
Sites / Locations
- Hôpitaux Universitaires de Strasbourg
Arms of the Study
Arm 1
Arm 2
Placebo Comparator
Experimental
Control
Light therapy